Search research articles
Contact Us
Filters
Showing results (141-150 of 238) with videos related to
Page
of 24
Sort By:
Blood
|
September 27, 2019
CAR T cell viability release testing and clinical outcomes: is there a lower limit?
Elise A Chong, Bruce L Levine, Stephan A Grupp, et al.
Blood Advances
|
February 17, 2026
CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multi-site, retrospective cohort review
Alexander W Rankin, Regina M Myers, Adam J Lamble, et al.
Science (New York, N.Y.)
|
July 27, 2023
In vivo hematopoietic stem cell modification by mRNA delivery
Laura Breda, Tyler E Papp, Michael P Triebwasser, et al.
Cytotherapy
|
August 23, 2025
Cytokine release syndrome risk model with T-cell engaging therapies
Pénélope Lafeuille, William A Blumentals, Claire Brulle-Wohlhueter, et al.
Transplantation and Cellular Therapy
|
May 18, 2024
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies
Rebecca A Gardner, Claire White, Magdi Elsallab, et al.
Science Advances
|
June 8, 2022
Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL
Zhiliang Bai, Steven Woodhouse, Ziran Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 27, 2019
Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Is Associated With Inferior Survival: A Report from the Children's Oncology Group
Natia Esiashvili, Xiaomin Lu, Ken Ulin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2020
Prospective Evaluation of Radiation Dose Escalation in Patients With High-Risk Neuroblastoma and Gross Residual Disease After Surgery: A Report From the Children's Oncology Group ANBL0532 Study
Kevin X Liu, Arlene Naranjo, Fan F Zhang, et al.
Blood
|
February 6, 2014
The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial
Michael A Pulsipher, Bryan Langholz, Donna A Wall, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 9, 2019
Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells
Andrew M Stein, Stephan A Grupp, John E Levine, et al.
Page
of 24
Search research articles
Search
Showing results (141-150 of 238) with videos related to
Sort By:
Page
of 24
Blood
|
September 27, 2019
CAR T cell viability release testing and clinical outcomes: is there a lower limit?
Elise A Chong, Bruce L Levine, Stephan A Grupp, et al.
Blood Advances
|
February 17, 2026
CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multi-site, retrospective cohort review
Alexander W Rankin, Regina M Myers, Adam J Lamble, et al.
Science (New York, N.Y.)
|
July 27, 2023
In vivo hematopoietic stem cell modification by mRNA delivery
Laura Breda, Tyler E Papp, Michael P Triebwasser, et al.
Cytotherapy
|
August 23, 2025
Cytokine release syndrome risk model with T-cell engaging therapies
Pénélope Lafeuille, William A Blumentals, Claire Brulle-Wohlhueter, et al.
Transplantation and Cellular Therapy
|
May 18, 2024
ACT To Sustain: Adoptive Cell Therapy To Sustain Access to Non-Commercialized Genetically Modified Cell Therapies
Rebecca A Gardner, Claire White, Magdi Elsallab, et al.
Science Advances
|
June 8, 2022
Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL
Zhiliang Bai, Steven Woodhouse, Ziran Zhao, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 27, 2019
Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Is Associated With Inferior Survival: A Report from the Children's Oncology Group
Natia Esiashvili, Xiaomin Lu, Ken Ulin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2020
Prospective Evaluation of Radiation Dose Escalation in Patients With High-Risk Neuroblastoma and Gross Residual Disease After Surgery: A Report From the Children's Oncology Group ANBL0532 Study
Kevin X Liu, Arlene Naranjo, Fan F Zhang, et al.
Blood
|
February 6, 2014
The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial
Michael A Pulsipher, Bryan Langholz, Donna A Wall, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
March 9, 2019
Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells
Andrew M Stein, Stephan A Grupp, John E Levine, et al.
Page
of 24